6Pestka EL, Hale AM, Johnson BL, et al. Cytochrome P450 testing for better psychiatric care[J].J Psyehosoc Nurs Ment Health Serv, 2007, 45 (10): 15--18.
7Bertilsson L, Metabolism of antidepressant and neuroleptic Durgs by cytochrome p450: clinical and interethnic aspects[J]. Clin Pharmacol Ther, 2007 82(5): 606--609.
8De Morals SM, Wilkinson GR, Blaisdell J, et al. The major genetic defect responsible for the polymorphism of S-mephenytoin in humans[J]. J Biol Chem, 1994, 269(22): 15419--15422.
9De Morais SM, Wilkinson GR, Blaisdell J, et al. Identification of a new genetic defect responsible for the polymorphism of S-mephenytoin in Japanese [J]. MolPharmacol, 1994, 46(4): 594--598.
10Sim SC, Risinger C, Dahl ML, et al. A common novel CYP2C19 gene variant causes ultrarapid drug response to proton pump inhibitors and antidepressants[J]. Clin Pharmacol Ther, 2006, 79(1):103 --113.
